Trials / Completed
CompletedNCT00595751
NeuroLex EEG-Based ADHD Assessment Aid, Pivotal Study
Best Estimate Diagnosis Used to Evaluate EEG in Association With ADHD in a Multi-Site, Clinical Sample of Children and Adolescents
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 300 (estimated)
- Sponsor
- Lexicor Medical Technology, LLC · Industry
- Sex
- All
- Age
- 6 Years – 18 Years
- Healthy volunteers
- Not accepted
Summary
The study will evaluate the effectiveness of a standardized EEG method with the intended clinical users in the intended clinical settings with the intended population (patients who would typically receive a clinician's evaluation for ADHD). Multiple sites will be examined to provide a sample of patients across numerous communities with different demographics. The goal is to evaluate if the predictive accuracy of EEG will not be inferior to that of a widely-used and extensively validated ADHD scale in the prediction of ADHD in the intended use population as evaluated by Best Estimate Diagnosis.
Conditions
Timeline
- Start date
- 2007-12-01
- Primary completion
- 2008-06-01
- Completion
- 2008-06-01
- First posted
- 2008-01-16
- Last updated
- 2008-07-30
Locations
10 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00595751. Inclusion in this directory is not an endorsement.